NASDAQ:VREX • US92214X1063
The current stock price of VREX is 13.29 USD. In the past month the price increased by 1.11%. In the past year, price increased by 2.56%.
ChartMill assigns a technical rating of 6 / 10 to VREX. When comparing the yearly performance of all stocks, VREX turns out to be only a medium performer in the overall market: it outperformed 61.84% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to VREX. VREX has an average financial health and profitability rating.
Over the last trailing twelve months VREX reported a non-GAAP Earnings per Share(EPS) of 1. The EPS increased by 78.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.35% | ||
| ROE | -14.88% | ||
| Debt/Equity | 0.79 |
11 analysts have analysed VREX and the average price target is 18.05 USD. This implies a price increase of 35.85% is expected in the next year compared to the current price of 13.29.
For the next year, analysts expect an EPS growth of -1.27% and a revenue growth 3.92% for VREX
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.63 | 197.518B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.98 | 175.875B | ||
| SYK | STRYKER CORP | 24.38 | 139.086B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.24 | 108.957B | ||
| IDXX | IDEXX LABORATORIES INC | 42.09 | 51.801B | ||
| BDX | BECTON DICKINSON AND CO | 11.38 | 51.46B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.96 | 46.035B | ||
| RMD | RESMED INC | 20.19 | 37.897B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.52 | 36.095B | ||
| DXCM | DEXCOM INC | 25.9 | 26.58B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah and currently employs 2,400 full-time employees. The company went IPO on 2017-01-20. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.
VAREX IMAGING CORP
1678 S Pioneer Rd
Salt Lake City UTAH 84104 US
CEO: Sunny S. Sanyal
Employees: 2400
Phone: 18019725000
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah and currently employs 2,400 full-time employees. The company went IPO on 2017-01-20. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.
The current stock price of VREX is 13.29 USD. The price decreased by -2.35% in the last trading session.
VREX does not pay a dividend.
VREX has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
VREX stock is listed on the Nasdaq exchange.
VAREX IMAGING CORP (VREX) will report earnings on 2026-05-06.